Shennon Biotechnologies
Shennon Bio
- Employees
- 11–50
- Business Model
- B2B
- Website
- shennonbio.com
- Total Funding
- $13.0M
- Last Round
- $13.0M SeedMar 2023
- Rounds
- 1
About
AI-powered drug discovery platform using ultrafast single cell-cell interaction mapping to identify novel targets.
Summary
Shennon Biotechnologies is an Artificial Intelligence company. It has raised $13.0M in total across 1 round, most recently a $13.0M Seed round in Mar 2023. Investors include DCVC (Data Collab), Formulate Ventures and Future Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2023
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...